UK markets closed

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
6.30+0.24 (+3.96%)
At close: 04:00PM EDT
6.30 0.00 (0.00%)
After hours: 05:04PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,052,115
-1,002,239
175,065
528,448
106,176
-
Depreciation & amortisation
1,827
1,600
1,400
1,500
3,564
-
Deferred income taxes
61,635
72,637
65,739
-333,294
0
-
Stock-based compensation
33,259
32,005
27,048
22,281
31,175
-
Change in working capital
35,251
11,279
2,820
17,731
-941
-
Accounts receivable
43,733
924
7,993
7,712
4,091
-
Inventory
-
-
0
0
648
0
Accounts payable
-851
12,380
-8,116
-2,644
-7,523
-
Other working capital
147,913
183,154
273,627
261,630
166,994
-
Other non-cash items
1,097,671
1,097,484
1,871
23,958
22,263
-
Net cash provided by operating activities
148,241
183,427
273,763
261,895
168,836
-
Cash flows from investing activities
Investments in property, plant and equipment
-328
-273
-136
-265
-1,842
-
Acquisitions, net
-
-1,026,045
0
0
-
-
Purchases of investments
-
-
-
-
0
0
Sales/maturities of investments
-
-
-
-
0
0
Net cash used for investing activities
-1,026,373
-1,026,318
-136
-265
-1,842
-
Cash flows from financing activities
Debt repayment
-125,000
-100,000
-120,699
0
0
-
Common stock repurchased
-
0
-126,394
-24,131
0
-
Other financing activities
-
-29,197
-
-
-
-34,207
Net cash used provided by (used for) financing activities
257,624
277,160
-237,553
-4,550
18,546
-
Net change in cash
-620,537
-565,784
36,074
257,080
185,540
-
Cash at beginning of period
742,077
657,938
621,864
364,784
179,244
-
Cash at end of period
121,569
92,154
657,938
621,864
364,784
-
Free cash flow
Operating cash flow
148,241
183,427
273,763
261,895
168,836
-
Capital expenditure
-328
-273
-136
-265
-1,842
-
Free cash flow
147,913
183,154
273,627
261,630
166,994
-